Sittner & Nelson’s Moderna MRNA Stock Holding History

Sittner & Nelson’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.1K	Hold	690	–	–	0.01%	325
2025 Q4	$28.3K	Hold	690	–	–	0.01%	316
2025 Q3	$17.8K	Hold	690	–	–	0.01%	330
2025 Q2	$19K	Hold	690	–	–	0.01%	326
2025 Q1	$19.6K	Hold	690	–	–	0.01%	314
2024 Q4	$28.7K	Sell	690 -300	-30%	-$14.3K	0.01%	260
2024 Q3	$66.2K	Hold	990	–	–	0.03%	207
2024 Q2	$118K	Sell	990 -150	-13%	-$19K	0.06%	148
2024 Q1	$121K	Buy	1,140 +50	+5%	+$5.04K	0.06%	150
2023 Q4	$108K	Buy	1,090 +510	+88%	+$42.9K	0.06%	153
2023 Q3	$59.9K	Hold	580	–	–	0.03%	187
2023 Q2	$70.5K	Hold	580	–	–	0.04%	179
2023 Q1	$89.1K	Hold	580	–	–	0.05%	168
2022 Q4	$104K	Hold	580	–	–	0.06%	162
2022 Q3	$69K	Hold	580	–	–	0.05%	185
2022 Q2	$83K	Buy	580 +60	+12%	+$8.58K	0.05%	165
2022 Q1	$90K	Buy	520 +120	+30%	+$20.2K	0.05%	159
2021 Q4	$102K	Buy	400 +50	+14%	+$14.6K	0.06%	145
2021 Q3	$135K	Sell	350 -300	-46%	-$111K	0.09%	117
2021 Q2	$153K	Hold	650	–	–	0.11%	104
2021 Q1	$85K	Hold	650	–	–	0.06%	136
2020 Q4	$68K	Buy	+650	New	+$65.8K	0.06%	140

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sittner & Nelson's MRNA Position: Q1 2026 in Review

Sittner & Nelson held its Moderna (MRNA) position steady in Q1 2026 at 690 shares worth $35.1K. The position accounts for 0.01% of the portfolio, ranked #325.

Sittner & Nelson first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $153K in Q2 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Sittner & Nelson held 690 shares of Moderna worth $35.1K as of Q1 2026.
Sittner & Nelson left its Moderna share count unchanged in Q1 2026.
Moderna made up 0.01% of Sittner & Nelson's portfolio in Q1 2026, its #325 holding.
Sittner & Nelson first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
Sittner & Nelson's Moderna position peaked at $153K in Q2 2021.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.